BACKGROUND: The Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS) trial has found that early aggressive statin therapy in patients with acute coronary syndrome (ACS) significantly reduces the plaque volume (PV) of non-culprit coronary lesions. The purpose of the present study was to evaluate clinical factors that have an impact on plaque regression using statin therapy. METHODS AND RESULTS: Serial intravascular ultrasound observations over 8-12 months were performed in 252 ACS patients receivingpitavastatin or atorvastatin. Linear regression analysis identified the presence of diabetes mellitus (DM) and PV at baseline as inhibiting factors, and serum remnant-like particle-cholesterol level at baseline as a significant factor significantly affecting the degree of plaque regression. Significant correlation between % change of PV and low-density lipoprotein cholesterol (LDL-C) level was found in patients with DM (n=73, P<0.05, r=0.4), whereas there was no significant correlation between the 2 parameters in patients without DM (n=178). CONCLUSIONS: The regression of coronary plaque induced by statin therapy after ACS was weaker in diabetic patients than their counterparts. Moreover, vigorous reduction of the LDL-C levels might induce a greater degree of plaque regression in ACS patients with DM.
RCT Entities:
BACKGROUND: The Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS) trial has found that early aggressive statin therapy in patients with acute coronary syndrome (ACS) significantly reduces the plaque volume (PV) of non-culprit coronary lesions. The purpose of the present study was to evaluate clinical factors that have an impact on plaque regression using statin therapy. METHODS AND RESULTS: Serial intravascular ultrasound observations over 8-12 months were performed in 252 ACS patients receiving pitavastatin or atorvastatin. Linear regression analysis identified the presence of diabetes mellitus (DM) and PV at baseline as inhibiting factors, and serum remnant-like particle-cholesterol level at baseline as a significant factor significantly affecting the degree of plaque regression. Significant correlation between % change of PV and low-density lipoprotein cholesterol (LDL-C) level was found in patients with DM (n=73, P<0.05, r=0.4), whereas there was no significant correlation between the 2 parameters in patients without DM (n=178). CONCLUSIONS: The regression of coronary plaque induced by statin therapy after ACS was weaker in diabeticpatients than their counterparts. Moreover, vigorous reduction of the LDL-C levels might induce a greater degree of plaque regression in ACS patients with DM.
Authors: Michael J Kraakman; Man Ks Lee; Annas Al-Sharea; Dragana Dragoljevic; Tessa J Barrett; Emilie Montenont; Debapriya Basu; Sarah Heywood; Helene L Kammoun; Michelle Flynn; Alexandra Whillas; Nordin Mj Hanssen; Mark A Febbraio; Erik Westein; Edward A Fisher; Jaye Chin-Dusting; Mark E Cooper; Jeffrey S Berger; Ira J Goldberg; Prabhakara R Nagareddy; Andrew J Murphy Journal: J Clin Invest Date: 2017-05-15 Impact factor: 14.808
Authors: Tessa J Barrett; Emilie Distel; Andrew J Murphy; Jiyuan Hu; Michael S Garshick; Yoscar Ogando; Jianhua Liu; Tomas Vaisar; Jay W Heinecke; Jeffrey S Berger; Ira J Goldberg; Edward A Fisher Journal: Circulation Date: 2019-09-30 Impact factor: 29.690
Authors: Prabhakara R Nagareddy; Andrew J Murphy; Roslynn A Stirzaker; Yunying Hu; Shiquing Yu; Rachel G Miller; Bhama Ramkhelawon; Emilie Distel; Marit Westerterp; Li-Shin Huang; Ann Marie Schmidt; Trevor J Orchard; Edward A Fisher; Alan R Tall; Ira J Goldberg Journal: Cell Metab Date: 2013-05-07 Impact factor: 27.287
Authors: Chujun Yuan; Jiyuan Hu; Saj Parathath; Lisa Grauer; Courtney Blachford Cassella; Svetlana Bagdasarov; Ira J Goldberg; Ravichandran Ramasamy; Edward A Fisher Journal: Diabetes Date: 2018-06-11 Impact factor: 9.461